Free Trial

Gemini Therapeutics (GMTX) SEC Filings & 10K Form

Gemini Therapeutics logo
$63.50 +0.96 (+1.53%)
(As of 11/21/2024 ET)

Recent Gemini Therapeutics SEC Filings

DateFilerForm TypeView
11/19/2024
11:15 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form EFFECT
11/19/2024
5:46 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:31 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:44 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form SC 13G/A
11/14/2024
3:33 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/08/2024
7:49 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:16 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
6:55 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
12:11 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form SC 13G
10/03/2024
3:29 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:05 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:39 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Savage William Jacob (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:06 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:23 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form S-3ASR
08/08/2024
7:06 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:15 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
4:10 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:15 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
9:06 AM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SC 13G
06/20/2024
7:00 PM
Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:27 PM
Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:19 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:15 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
06/14/2024
6:36 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:15 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:07 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
3:05 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
5:27 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
4:02 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
3:14 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
4:25 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
7:54 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
7:00 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
7:15 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
3:40 PM
Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:45 PM
Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
5:47 PM
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
6:36 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:38 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Yu Jonathan Yen-Wen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
50-year Wall Street legend: “Sell this tech stock NOW” (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.
03/01/2024
6:39 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:42 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:49 PM
Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
4:38 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
4:33 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:43 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:33 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:37 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:51 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form SC 13G/A
02/09/2024
7:50 AM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/07/2024
7:10 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:24 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form SC 13G/A
02/06/2024
3:55 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
4:44 PM
Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
4:47 PM
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
4:48 PM
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
4:12 PM
Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
4:12 PM
Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
8:44 PM
Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
8:51 PM
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:24 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
MacDonald Brian Richard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:15 PM
Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:16 PM
Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:28 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
5:04 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
5:09 PM
Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
5:11 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144/A
12/15/2023
5:15 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144/A
12/15/2023
5:18 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144/A
12/15/2023
3:48 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
12/14/2023
7:13 PM
Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
7:14 PM
Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:40 PM
Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:44 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:15 PM
Bryce Joanne (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:15 PM
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:53 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:58 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:00 PM
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:03 PM
Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:42 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
3:19 PM
Bryce Joanne (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
3:19 PM
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
7:35 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
11:11 AM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
11:15 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form EFFECT
12/05/2023
3:51 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form 424B5
12/05/2023
3:53 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form POS AM
12/05/2023
3:53 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form POS AM
12/05/2023
3:21 PM
Bryce Joanne (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now
11/29/2023
11:15 PM
Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GMTX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners